Gene Therapy for Hemophilia B: Results From the Phase I/II 101HEMB 1/2 Studies

The Phase I/II open-label, single-arm, multicenter, dose-finding 101HEMB01 study examined the safety/efficacy of DTX101 in adult males with HemB; the 101HEMB02 follow-up study assessed long-term outcomes.